Stay updated on Seladelpar in PBC & Hepatic Impairment Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in PBC & Hepatic Impairment Clinical Trial page.
Latest updates to the Seladelpar in PBC & Hepatic Impairment Clinical Trial page
- ChecktodayChange DetectedThe website has added new clinical study information including a Gilead study with multiple locations in the U.S. and Korea, while removing details about a previous study and its associated contacts.SummaryDifference12%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
- Check22 days agoChange DetectedGilead Sciences has been added with a new revision v2.11.0, while CymaBay Therapeutics, Inc. has been removed along with an older revision v2.10.5.SummaryDifference2%
- Check30 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference1%
- Check44 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check65 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
Stay in the know with updates to Seladelpar in PBC & Hepatic Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in PBC & Hepatic Impairment Clinical Trial page.